Global Female Contraceptive Market 2018-2022

◆상품코드 : IRTNTR20529
◆발행일 : 2018년 2월
◆페이지수 : 136
◆보고서 형식 : PDF / 영문
◆납품 방식 : Email
◆조사대상 지역 : 글로벌
◆산업분야 : 미분류
◆발행회사(조사회사) : Technavio
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥378,000 -> 환산 ₩3,780,000견적의뢰/구매/질문FORM
Five User¥432,000 -> 환산 ₩4,320,000견적의뢰/구매/질문FORM
Enterprise License¥540,000 -> 환산 ₩5,400,000견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

About Female Contraceptive
Female contraceptives are used by women for family planning and to avoid unintended pregnancies.
Technavio’s analysts forecast the global female contraceptive market to grow at a CAGR of 3.44 % during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global female contraceptive market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of female contraceptive.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Female Contraceptive Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• Bayer
• Lupin Pharmaceuticals
• Merck
• Pfizer
• Foundation Consumer Healthcare

[Market driver]
• Evolving consumer perspective
• For a full, detailed list, view our report

[Market challenge]
• Irregularities in sex education in developed countries
• For a full, detailed list, view our report

[Market trend]
• Increase in use of female condoms
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

[조사보고서 목차]

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Overview
• Comparison by product
• Female contraceptive devices
• Female contraceptive drugs
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Female contraceptive market in Americas
• Female contraceptive market in EMEA
• Female contraceptive market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Increase in use of female condoms
• High disposable income in US
• Advent of smart condoms

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan
• Bayer1
• Lupin Pharmaceuticals
• Merck
• Pfizer
• Foundation Consumer Healthcare
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits] Exhibit 01: Parent market
Exhibit 02: Global contraceptive market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global female contraceptive market: Segments
Exhibit 05: Advantages and disadvantages of different types of contraceptives
Exhibit 06: Market definition: Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global female contraceptive market 2017-2022 ($ millions)
Exhibit 10: Global female contraceptive market: Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition: Five forces 2017
Exhibit 19: Global female contraceptive market: Segmentation by product 2017-2022 (% share)
Exhibit 20: Types of female contraceptive devices and drugs
Exhibit 21: Comparison by product
Exhibit 22: Global female contraceptive devices market 2017-2022 ($ millions)
Exhibit 23: Global female contraceptive devices market: Year-over-year growth 2018-2022 (%)
Exhibit 24: Global IUDs market 2017-2022 ($ millions)
Exhibit 25: Global female sterilization market 2017-2022 ($ millions)
Exhibit 26: Global subdermal contraceptive implants market 2017-2022 ($ millions)
Exhibit 27: Global vaginal rings market 2017-2022 ($ millions)
Exhibit 28: Global female condoms market 2017-2022 ($ millions)
Exhibit 29: Global nonsurgical permanent contraception market 2017-2022 ($ millions)
Exhibit 30: Global contraceptive diaphragms market 2017-2022 ($ millions)
Exhibit 31: Global contraceptive sponges market 2017-2022 ($ millions)
Exhibit 32: Global female contraceptive drugs market 2017-2022 ($ millions)
Exhibit 33: Global female contraceptive drugs market: Year-over-year growth 2018-2022 (%)
Exhibit 34: Global birth control pills market 2017-2022 ($ millions)
Exhibit 35: Global emergency contraceptive pills market 2017-2022 ($ millions)
Exhibit 36: Market opportunity by product
Exhibit 37: Customer landscape
Exhibit 38: Global female contraceptive market: Segmentation by geography 2017-2022 (% share)
Exhibit 39: Regional comparison
Exhibit 40: Female contraceptive market in Americas 2017-2022 ($ millions)
Exhibit 41: Female contraceptive market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 42: Top-three countries in Americas
Exhibit 43: Female contraceptive market in EMEA 2017-2022 ($ millions)
Exhibit 44: Female contraceptive market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 45: Top-three countries in EMEA
Exhibit 46: Female contraceptive market in APAC 2017-2022 ($ millions)
Exhibit 47: Female contraceptive market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 48: Top-three countries in APAC
Exhibit 49: Market opportunity
Exhibit 50: State-wise disposable income in US 2015
Exhibit 51: Vendor landscape
Exhibit 52: Landscape disruption
Exhibit 53: Vendors covered
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors
Exhibit 57: Allergan: Overview
Exhibit 58: Allergan: Business segments
Exhibit 59: Allergan: Organizational developments
Exhibit 60: Allergan: Geographic focus
Exhibit 61: Allergan: Segment focus
Exhibit 62: Allergan: Key offerings
Exhibit 63: Bayer: Overview
Exhibit 64: Bayer: Business segments
Exhibit 65: Bayer: Organizational developments
Exhibit 66: Bayer AG: Geographic focus
Exhibit 67: Bayer: Segment focus
Exhibit 68: Bayer: Key offerings
Exhibit 69: Lupin Pharmaceuticals: Overview
Exhibit 70: Lupin Pharmaceuticals: Business segments
Exhibit 71: Lupin Pharmaceuticals: Organizational developments
Exhibit 72: Lupin Pharmaceuticals: Geographic focus
Exhibit 73: Lupin Pharmaceuticals: Segment focus
Exhibit 74: Lupin Pharmaceuticals: Key offerings
Exhibit 75: Merck: Overview
Exhibit 76: Merck: Business segments
Exhibit 77: Merck: Organizational developments
Exhibit 78: Merck: Geographic focus
Exhibit 79: Merck: Segment focus
Exhibit 80: Merck: Key offerings
Exhibit 81: Pfizer: Overview
Exhibit 82: Pfizer: Business segments
Exhibit 83: Pfizer: Organizational development
Exhibit 84: Pfizer: Geographic focus
Exhibit 85: Pfizer: Segment focus
Exhibit 86: Pfizer: Key offerings
Exhibit 87: Foundation Consumer Healthcare: Overview
Exhibit 88: Foundation Consumer Healthcare: Business segments
Exhibit 89: Foundation Consumer Healthcare: Organizational developments
Exhibit 90: Foundation Consumer Healthcare: Geographic focus
Exhibit 91: Foundation Consumer Healthcare: Segment focus
Exhibit 92: Foundation Consumer Healthcare: Key offerings



[조사보고서에 언급된 기업]
Allergan, Bayer, Lupin Pharmaceuticals, Merck, Pfizer, and Foundation Consumer Healthcare

[보고서에 포함된 내용]
세계시장규모, 세그멘트별 시장규모, 시장동향, 시장예측, 관련 기업정보 등

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Global Female Contraceptive Market 2018-2022]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆